Combination of Bevacizumab and Docetaxel in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer: A Phase 2 StudyGiuseppe Di Lorenzo, Sabino De Placido, William D. Figg et al.|European Urology|2008Cited by 128
Neutrophil percentage-to-albumin Ratio Predicts Mortality in Bladder Cancer Patients Treated With Neoadjuvant Chemotherapy Followed By Radical CystectomyMatteo Ferro, Mihai Dorin Vartolomei, Dragoș-Florin Babă et al.|Future Science OA|2021Cited by 79
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumorMatteo Ferro, Carlo Buonerba, Giuseppe Di Lorenzo et al.|World Journal of Urology|2019Cited by 62
A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumorsSavio Domenico Pandolfo, Riccardo Autorino, Clara Cerrato et al.|Asian journal of urology|2023Cited by 57
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancerMatteo Ferro, Mihai Dorin Vartolomei, Biagio Barone et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 56